eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized


Advanced tools       Explore eHealthMe

From FDA reports: drug interactions between Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane for a Female patient aged 66

This is a personalized study for a 66 year old female patient. The study is created by eHealthMe based on reports of 3 people who take the same drugs and have drug interactionsfrom FDA.

On Jul, 22, 2014: 3 people who reported to have interactions when taking Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane are studied

Trend of Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane's drug interactions, side effects, and effectiveness reports (3079597)

Information of the patient in this study:

Age: 66

Gender: female

Conditions: General Anaesthesia, Postoperative Analgesia

Drugs taking:
- Nimbex
- Etomidate
- Sufentanil
- Propofol: used for < 1 month
- Naropin: used for < 1 month
- Humalog
- Xanax
- Perindopril Erbumine
- Sevoflurane
- Naropin: used for < 1 month

Drug interactions have: Ventricular Fibrillation, Respiratory Arrest, Overdose, Hypoproteinaemia, Cardiac Arrest

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 66 (±5):

InteractionNumber of reports
Ventricular Fibrillation (abnormally irregular heart rhythm)1 (100.00%)
Respiratory Arrest (cessation of normal respiration due to failure of the lungs to function effectively)1 (100.00%)
Overdose1 (100.00%)
Hypoproteinaemia (too little prolactin circulating in the blood)1 (100.00%)
Cardiac Arrest1 (100.00%)

Most common interactions experienced by females aged 66 (±5) in the use of Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane:

InteractionNumber of reports
Respiratory Arrest (cessation of normal respiration due to failure of the lungs to function effectively)1
Ventricular Fibrillation (abnormally irregular heart rhythm)1
Overdose1
Hypoproteinaemia (too little prolactin circulating in the blood)1
Cardiac Arrest1

Most common interactions experienced by females aged 66 (±5) in long term use of Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Ventricular Fibrillation (abnormally irregular heart rhythm)3 (100.00%)
Respiratory Arrest (cessation of normal respiration due to failure of the lungs to function effectively)3 (100.00%)
Overdose3 (100.00%)
Hypoproteinaemia (too little prolactin circulating in the blood)3 (100.00%)
Cardiac Arrest3 (100.00%)

Most common interactions experienced by people in the use of Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane:

InteractionNumber of reports
Respiratory Arrest (cessation of normal respiration due to failure of the lungs to function effectively)3
Ventricular Fibrillation (abnormally irregular heart rhythm)3
Overdose3
Hypoproteinaemia (too little prolactin circulating in the blood)3
Cardiac Arrest3

Most common interactions experienced by people in long term use of Nimbex, Etomidate, Sufentanil, Propofol, Naropin, Humalog, Xanax, Perindopril Erbumine, Sevoflurane:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.